Article
Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy.
Antiviral therapy - 1 Jan 2017
Ogawa Eiichi, Furusyo Norihiro, Murata Masayuki, Shimizu Motohiro, Toyoda Kazuhiro, Hotta Taeko, Uchiumi Takeshi, Hayashi Jun
Abstract excerpt
BACKGROUND: On-treatment HCV kinetics play an invaluable role in evaluating the efficacy of interferon-based therapies. However, the importance of HCV RNA monitoring has not been well discussed concerning treatment with sofosbuvir (SOF)-based regimens, especially for the utility of the Abbott RealTime HCV (ART) assay. METHODS: This study consisted of 151 patients infected with HCV genotype-1 or -2, including...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.